Literature DB >> 1870452

Ultrastructural immunolocalization of osteopontin in metaphyseal and cortical bone.

K Hultenby1, F P Reinholt, A Oldberg, D Heinegård.   

Abstract

The ultrastructural localization of osteopontin in bone was determined especially focussing on the relationship to bone forming cells, i.e. osteoblasts and osteocytes. Thus, rat metaphyseal and cortical bone was fixed in a mixture of low concentration glutar- and paraformaldehyde and embedded at low temperature in Lowicryl K11M. Polyclonal antibodies raised against rat osteopontin fusion protein were incubated on ultrathin sections and protein G coated with 5-nm colloidal gold was used for detection. The results demonstrate most intensive labeling in the mineralization front of newly formed bone; whereas lower concentration of label was found in the osteoid both in metaphyseal and cortical bone. The concentration of marker was substantially higher in newly formed bone near osteoblasts compared to bone constituting the osteocyte lacuna. Intracellularly the prevailing localization of label was to large Golgi vesicles in osteoblasts. Only focally local accumulation of marker was seen at the cell/osteoid surface. The observations suggest a function of osteopontin also in the mineral turnover of newly formed bone.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1870452     DOI: 10.1016/s0934-8832(11)80160-5

Source DB:  PubMed          Journal:  Matrix        ISSN: 0934-8832


  16 in total

1.  Polarization and secretion of cathepsin K precede tartrate-resistant acid phosphatase secretion to the ruffled border area during the activation of matrix-resorbing clasts.

Authors:  Karin Hollberg; Joakim Nordahl; Kjell Hultenby; Silwa Mengarelli-Widholm; Göran Andersson; Finn P Reinholt
Journal:  J Bone Miner Metab       Date:  2005       Impact factor: 2.626

2.  Staphylococcus aureus causing osteomyelitis binds to a nonapeptide sequence in bone sialoprotein.

Authors:  C Rydén; H S Tung; V Nikolaev; A Engström; A Oldberg
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

3.  Age- and gender-related changes in the distribution of osteocalcin in the extracellular matrix of normal male and female bone. Possible involvement of osteocalcin in bone remodeling.

Authors:  R T Ingram; Y K Park; B L Clarke; L A Fitzpatrick
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

4.  Gene expression and distribution of key bone turnover markers in the callus of estrogen-deficient, vitamin D-depleted rats.

Authors:  Gunhild Melhus; S H Brorson; E S Baekkevold; G Andersson; R Jemtland; O K Olstad; F P Reinholt
Journal:  Calcif Tissue Int       Date:  2010-05-22       Impact factor: 4.333

5.  Bone sialoprotein mRNA expression and ultrastructural localization in fetal porcine calvarial bone: comparisons with osteopontin.

Authors:  J Chen; M D McKee; A Nanci; J Sodek
Journal:  Histochem J       Date:  1994-01

6.  Macrophages express osteopontin during repair of myocardial necrosis.

Authors:  C E Murry; C M Giachelli; S M Schwartz; R Vracko
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

7.  Bone cell matrix promotes the adhesion of human prostatic carcinoma cells via the alpha 2 beta 1 integrin.

Authors:  P J Kostenuik; O Sanchez-Sweatman; F W Orr; G Singh
Journal:  Clin Exp Metastasis       Date:  1996-01       Impact factor: 5.150

8.  Ultrastructural immunolocalization of fibronectin in epiphyseal and metaphyseal bone of young rats.

Authors:  J Nordahl; S Mengarelli-Widholm; K Hultenby; F P Reinholt
Journal:  Calcif Tissue Int       Date:  1995-12       Impact factor: 4.333

9.  Matrix proteins with high affinity for calcium ions are associated with mineralization within the elastic fibers of pseudoxanthoma elasticum dermis.

Authors:  M B Contri; F Boraldi; F Taparelli; A De Paepe; I P Ronchetti
Journal:  Am J Pathol       Date:  1996-02       Impact factor: 4.307

10.  Osteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression.

Authors:  M A Chellaiah; N Kizer; R Biswas; U Alvarez; J Strauss-Schoenberger; L Rifas; S R Rittling; D T Denhardt; K A Hruska
Journal:  Mol Biol Cell       Date:  2003-01       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.